ArticlemBio2026

Fc-engineered broadly neutralizing antibodies overcome cytokine-induced CD16 cleavage to drive potent ADCC against diverse HIV-1 strains.

Claudia Melo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.